← back to search

Shannon Marshall

Immunocore (United States) · US
Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, and Immunotherapy and Immune Responses.
h-index
24
citations
1,905
works
62
NIH funding
primary concept
email

Recent publications

Phosphoribosyl modification of poly-ubiquitin chains at the Legionella-containing vacuole prohibiting autophagy adaptor recognition
Nature Communications 2024cited by 21position: middledoi
694 Phase 1 safety and efficacy of brenetafusp, a PRAME × CD3 ImmTAC bispecific, in post-checkpoint cutaneous melanoma (CM)
Regular and Young Investigator Award Abstracts 2024cited by 2position: middledoi
DNA-PKcs promotes fork reversal and chemoresistance
Molecular Cell 2022cited by 49position: middledoi
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer
Molecular Cancer Therapeutics 2021cited by 87position: middledoi
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
Nature Communications 2020cited by 87position: middledoi
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Leukemia 2018cited by 245position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marcus B. Smolka · Cornell University2 papers (2022–2024)Yuan Yuan · Nanjing University of Chinese Medicine1 papers (2024–2024)Erika Hamilton · Duke Medical Center1 papers (2021–2021)Claire F. Friedman · University of Toronto1 papers (2024–2024)Oliver Bechter · Universitair Ziekenhuis Leuven1 papers (2024–2024)Manish R. Patel · Centers for Disease Control and Prevention1 papers (2021–2021)Marcus O. Butler · Beaumont Hospital1 papers (2020–2020) · 1 papers (2020–2020)Daniel G. Olson · University of Illinois Chicago1 papers (2024–2024)Diego Dibitetto · University of Bern1 papers (2022–2022)Sven Rottenberg · Netherlands Comprehensive Cancer Organisation1 papers (2022–2022) · 1 papers (2022–2022)Mayukh Das · Texas A&M University1 papers (2021–2021)Fiona Thistlethwaite · University of Manchester1 papers (2024–2024) · 1 papers (2022–2022)Antoinette R. Tan · Levine Cancer Institute1 papers (2021–2021)Célèste Lebbé · Assistance Publique – Hôpitaux de Paris1 papers (2024–2024)Jumana Badar · Cornell University1 papers (2022–2022)Omid Hamid · University Hospital Münster1 papers (2024–2024)Paolo A. Ascierto · Parker Institute for Cancer Immunotherapy1 papers (2020–2020)